Association of POCD With Circulating Biomarkers in Patients Undergoing TUR of Bladder Tumor

Recruiting Observational Study
Cognitive Decline Urinary Bladder Cancer Frail Biomarker General Anesthesia Hand Grip Strength Cognitive Testing Comorbidities Demographic Data Socio-economic Status Perioperative Complications
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Any
Study type
Observational
Participants needed
42 (estimated)
Sponsor
Osijek University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Bladder tumor is one of the most widespread tumors in the world, with increasing prevalence at the global level. One of the procedures in patients with bladder tumors is transurethral resection of the bladder (TURM) most often performed endoscopically under general anesthesia. This patient population has certain characteristics in common. One of them is exposure to common risk factors for the form…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * adult patients from 18-80 years, * elective operations of tumor bladder cancer (TUR), * patients can communicate, * patients who can sign the information consent and questionnaires Exclusion Criteria: * patients under the age of 18, * patients above 80 years, * patients who …
Contacts

Ana Cicvarić

+385 511 502

annikaadv@gmail.com

CONTACT

Slavica Kvolik, MD, PhD

+385 511 502

slavica.kvolik@gmail.com

CONTACT